Search Results - Venner, Christopher

Three-Dimensional Reconstructed Bone Marrow Matrix Culture Improves the Viability of Primary Myeloma Cells In-Vitro via a STAT3-Dependent Mechanism by Huang, Yung-Hsing, Almowaled, Meaad, Li, Jing, Venner, Christopher, Sandhu, Irwindeep, Peters, Anthea, Lavasanifar, Afsaneh, Lai, Raymond

Get full text Get full text Get full text

Frequent Occurrence of Highly Expanded but Unrelated B-Cell Clones in Patients with Multiple Myeloma by Kriangkum, Jitra, Motz, Sarah N., Debes Marun, Carina S., Lafarge, Sandrine T., Gibson, Spencer B., Venner, Christopher P., Johnston, James B., Belch, Andrew R., Pilarski, Linda M.

Get full text Get full text Get full text

Constitutive Activation of STAT3 in Myeloma Cells Cultured in a Three-Dimensional, Reconstructed Bone Marrow Model by Huang, Yung-Hsing, Molavi, Ommoleila, Alshareef, Abdulraheem, Haque, Moinul, Wang, Qian, Chu, Michael P., Venner, Christopher P., Sandhu, Irwindeep, Peters, Anthea C., Lavasanifar, Afsaneh, Lai, Raymond

Get full text Get full text Get full text

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis by Sachchithanantham, Sajitha, Offer, Mark, Venner, Christopher, Mahmood, Shameem A., Foard, Darren, Rannigan, Lisa, Lane, Thirusha, Gillmore, Julian D., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Get full text Get full text Get full text

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome by Venner, Christopher P., Woltosz, Joanna Wegrzyn, Nevill, Thomas J., Deeg, H. Joachim, Caceres, Gisela, Platzbecker, Uwe, Scott, Bart L., Sokol, Lubomir, Sung, Sandy, List, Alan F., Karsan, Aly

Get full text Get full text Get full text

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis by Dungu, Jason, Whelan, Carol J, Gibbs, Simon D, Pinney, Jennifer H, Banypersad, Sanjay M, Venner, Christopher P, Lachmann, Helen J, Wechalekar, Ashutosh, Gillmore, Julian D, Hawkins, Philip N, Anderson, Lisa

Get full text Get full text

Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Dat... by Watanabe, Sharon M., Faily, Viane, Mawani, Asifa, Huot, Ann, Tarumi, Yoko, Potapov, Alexei, Fassbender, Konrad, Fairchild, Alysa, Joy, Anil A., King, Karen M., Roa, Wilson, Venner, Christopher P., Baracos, Vickie E.

Get full text Get full text Get full text

Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting by Venner, Christopher P., Gillmore, Julian D., Sachchithanantham, Sajitha, Mahmood, Shameem, Lane, Thirusha, Foard, Darren, Roussel, Murielle, Rannigan, Lisa, Gibbs, Simon DJ, Pinney, Jennifer H, Whelan, Carol J., Lachmann, Helen J., Hawkins, Philip N., Wechalekar, Ashutosh D.

Get full text Get full text Get full text

Systemic Amyloidosis in England: an epidemiological study by Pinney, Jennifer H, Smith, Colette J, Taube, Jessi B, Lachmann, Helen J, Venner, Christopher P, Gibbs, Simon D J, Dungu, Jason, Banypersad, Sanjay M, Wechalekar, Ashutosh D, Whelan, Carol J, Hawkins, Philip N, Gillmore, Julian D

Get full text Get full text Get full text

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III) by Jaccard, Arnaud, Comenzo, Raymond L., Hari, Parameswaran, Hawkins, Philip N., Roussel, Murielle, Morel, Pierre, Macro, Margaret, Pellegrin, Jean-Luc, Lazaro, Estibaliz, Mohty, Dania, Mercie, Patrick, Decaux, Olivier, Gillmore, Julian, Lavergne, David, Bridoux, Frank, Wechalekar, Ashutosh D., Venner, Christopher P.

Get full text Get full text Get full text

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma by Bahlis, Nizar J., Sutherland, Heather, White, Darrell, Sebag, Michael, Lentzsch, Suzanne, Kotb, Rami, Venner, Christopher P., Gasparetto, Cristina, Del Col, Aldo, Neri, Paola, Reece, Donna, Kauffman, Michael, Shacham, Sharon, Unger, T. J., Jeha, Jacqueline, Saint-Martin, Jean-Richard, Shah, Jatin, Chen, Christine

Get full text Get full text Get full text

Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database by McCurdy, Arleigh, Venner, Christopher P., Masih-Khan, Esther, Louzada, Martha, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Jimenez-Zepeda, Victor H., Kotb, Rami, Kardjadj, Moustafa, Mian, Hira, White, Darrell, Stakiw, Julie, Aslam, Muhammad, Reiman, Anthony, Gul, Engin, Reece, Donna

Get full text Get full text Get full text

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database by Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.

Get full text Get full text Get full text

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome by Pinney, Jennifer H., Whelan, Carol J., Petrie, Aviva, Dungu, Jason, Banypersad, Sanjay M., Sattianayagam, Prayman, Wechalekar, Ashutosh, Gibbs, Simon D. J., Venner, Christopher P., Wassef, Nancy, McCarthy, Carolyn A., Gilbertson, Janet A., Rowczenio, Dorota, Hawkins, Philip N., Gillmore, Julian D., Lachmann, Helen J.

Get full text Get full text Get full text

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis by Mian, Hira, Eisfeld, Christine, Venner, Christopher P., Masih-Khan, Esther, Kardjadj, Moustafa, Jimenez-Zepeda, Victor H., Khandanpour, Cyrus, Lenz, Georg, McCurdy, Arleigh, Sebag, Michael, Song, Kevin, LeBlanc, Richard, White, Darrell, Stakiw, Julie, Reiman, Anthony, Louzada, Martha, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna

Get full text Get full text Get full text

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma by Facon, Thierry, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell J., Karlin, Lionel, Benboubker, Lotfi, Rigaudeau, Sophie, Rodon, Philippe, Voog, Eric, Yoon, Sung-Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Twumasi-Ankrah, Philip, Yung, Godwin, Rifkin, Robert M., Moreau, Philippe, Lonial, Sagar, Kumar, Shaji K., Richardson, Paul G., Rajkumar, S. Vincent

Get full text Get full text Get full text

Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA by Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja

Get full text Get full text Get full text

Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients by Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Baljevic, Muhamed, Lentzsch, Suzanne, Rossi, Adriana C., Kotb, Rami, White, Darrell, Bahlis, Nizar J., Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, Ammu, Sonia, Ben-Shahar, Osnat, DeCastro, Andrew, Van Domelen, Dane, Zhou, Tianjun, Zhang, Chris, Bentur, Ohad S., Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea

Get full text Get full text Get full text

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group by Leung, Nelson, Bridoux, Frank, Batuman, Vecihi, Chaidos, Aristeidis, Cockwell, Paul, D’Agati, Vivette D., Dispenzieri, Angela, Fervenza, Fernando C., Fermand, Jean-Paul, Gibbs, Simon, Gillmore, Julian D., Herrera, Guillermo A., Jaccard, Arnaud, Jevremovic, Dragan, Kastritis, Efstathios, Kukreti, Vishal, Kyle, Robert A., Lachmann, Helen J., Larsen, Christopher P., Ludwig, Heinz, Markowitz, Glen S., Merlini, Giampaolo, Mollee, Peter, Picken, Maria M., Rajkumar, Vincent S., Royal, Virginie, Sanders, Paul W., Sethi, Sanjeev, Venner, Christopher P., Voorhees, Peter M., Wechalekar, Ashutosh D., Weiss, Brendan M., Nasr, Samih H.

Get full text Get full text Get full text

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study by Royal, Virginie, Leung, Nelson, Troyanov, Stéphan, Nasr, Samih H., Écotière, Laure, LeBlanc, Richard, Adam, Benjamin A., Angioi, Andrea, Alexander, Mariam P., Asunis, Anna Maria, Barreca, Antonella, Bianco, Paola, Cohen, Camille, Drosou, Maria E., Fatima, Huma, Fenoglio, Roberta, Gougeon, François, Goujon, Jean-Michel, Herrera, Guillermo A., Knebelmann, Bertrand, Lepori, Nicola, Maletta, Francesca, Manso, Rita, Motwani, Shveta S., Pani, Antonello, Rabant, Marion, Rennke, Helmut G., Rocatello, Dario, Rosenblum, Frida, Sanders, Paul W., Santos, Afonso, Soto, Karina, Sis, Banu, Touchard, Guy, Venner, Christopher P., Bridoux, Frank

Get full text Get full text Get full text